Scientists at UC Riverside have built a tool that lets them watch how inflammation begins inside human cells. Their work appears in Free Radical Biology and Medicine.

The team worked with cells that line the airways, since these touch inhaled pollutants that can provoke inflammation. Understanding the cellular trigger could eventually point to ways of keeping the response from becoming chronic.

The project centered on DNA in mitochondria, the structures that provide much of a cell’s energy. Mitochondria hold their own DNA, distinct from the DNA in the nucleus. Previous work has established that this mitochondrial DNA is central to immune responses. Many chemicals, however, harm DNA in both locations, which makes it difficult to separate the contribution of each. 

“This tool gives us a new way to investigate how mitochondrial injury contributes to inflammation,” said corresponding author Linlin Zhao.

The investigators focused on alkylation, a form of damage in which small chemical groups attach to DNA building blocks. Certain pollutants and medicines cause it, and it can also arise from routine chemical reactions within cells. The team wanted to learn whether alkylation inside mitochondria could trigger inflammation.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

Co-author Anal Jana began with chlorambucil, a chemotherapy drug known to damage DNA, and attached a chemical group that draws the drug into mitochondria. “I designed the molecule by combining my expertise in chemical synthesis with the Zhao lab’s extensive experience in mitochondrial biology,” Jana said.

Anthony Rios, the study’s first author, applied the modified compound to lab-grown human airway cells. Nuclear DNA stayed undamaged. The team did find injured mitochondrial DNA in the fluid surrounding the mitochondria. There, such molecules can act as injury signals and switch on genes tied to immune response and inflammation. 

The dose made a difference. With a lower amount, the team observed changes in mitochondrial DNA while the mitochondria continued to act fairly normally, using oxygen at their typical rate. With a higher amount, the DNA damage was more extensive and the mitochondria behaved abnormally.

Zhao’s group intends to test versions of the molecule that inflict varying levels of damage. They hope to determine exactly how much damage is needed to start inflammatory signaling, and whether aging cells respond differently. Another open question is which of the damage-related molecules found outside the mitochondria helped drive the response.

Pinpointing what puts inflammation in motion could eventually help scientists identify where to step in before the response lasts long enough to contribute to disease.

“If we can figure out which steps set inflammation in motion, we can start looking for ways to intervene before it becomes chronic,” Zhao said.